MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    A cortical neural signature of motor interruption in patients with Parkinson’s disease and freezing of gait

    J. Baarbé, M. Brown, U. Saha, K. Lizarraga, A. Weissbach, N. Drummond, C. Rinchon, P. Kapoor, J. Saravanamuttu, R. Chen (Toronto, ON, Canada)

    Objective: To investigate whether cortical oscillations involved in sensorimotor and perceptual processes [alpha (8-12 Hz), low beta (13-20 Hz) and high beta (21-35 Hz)] change…
  • 2018 International Congress

    Microstructural Changes in Normal Appearing White Matter in Parkinson’s Disease (PD) Correlate with Motor, Tremor, and Neuropsychiatric Scores

    J. Kim, T. Baumeister, M. McKeown (Vancouver, BC, Canada)

    Objective: To determine if microstructural changes in the normal appearing white matter of PD are associated with clinical manifestations of disease. Background: White matter (WM)…
  • 2018 International Congress

    Subthalamic Nucleus Local Field Potential Beta Activity in Chinese Advanced PD Patients

    J. Wu, J. Li, C. Xu, S. Mei, Y. Zhang (Minneapolis, MN, USA)

    Objective: To test if the β oscillations of subthalamic nucleus (STN) local field potential (LFP) in Chinese advanced Parkinson’s disease (PD) patients are similar with…
  • 2018 International Congress

    Temporal evolution of biomarkers from healthy ageing, isolated REM sleep behavior to early Parkinson’s disease

    B. Mollenhauer, M-L. Muntean, J. Zimmermann, K. Focke, T. Wicke, J. Ebentheuer, M. Schaumburg, E. Lang, WH. Oertel, F. Sixel-Döring, C. Trenkwalder (Kassel, Germany)

    Objective: To study the temporal evolution of biomarkers of various modalities in healthy ageing controls (HC), the prodromal condition of isolated REM sleep behavior disorder…
  • 2018 International Congress

    α-synuclein propagation via olfactory pathway in non-human primate model

    M. Sawamura, H. Onoe, N. Uemura, T. Isa, R. Takahashi (Kyoto, Japan)

    Objective: Recent studies have revealed that intracerebral injection of synthetic α-synuclein (α-syn) fibrils into olfactory bulb (OB) of mice induced prion-like propagation of α-syn aggregates…
  • 2018 International Congress

    Subthalamic nucleus stimulation normalises effort-based decision-making in Parkinson’s disease

    C. Atkinson-Clement, E. Cavazzini, A. Zénon, T. Witjas, F. Fluchère, C. Baunez, JP. Azulay, A. Eusebio (Aix-en-Provence, France)

    Objective: To compare the influence of levodopa and subthalamic nucleus stimulation (STN-DBS) on effort-based decision-making in Parkinson’s disease (PD). Background: Idiopathic PD is a neurodegenerative…
  • 2018 International Congress

    Utilizing latent class analysis to explore the sleep disturbance subtypes in Parkinson’s disease patients

    H.J. Yang, H.J. Kim, S.J. Kim (Ulsan, Republic of Korea)

    Objective: The aim of this study was to analyze whether distinct sleep disturbance subtypes could be empirically identified in patients with Parkinson’s disease (PD) based…
  • 2018 International Congress

    Quality of Life in Parkinson’s Disease: Impact of Depression and Apathy

    H. Nagayama (Tokyo, Japan)

    Objective: The aim of this study is to investigate whether depression and apathy are independently related to QoL in patients with PD. Therefore, we performed…
  • 2018 International Congress

    Serum Uric Acid Level and Its Relationship to Non-Motor Symptomatology in Parkinson’s disease

    O. Odeniyi, N. Okubadejo, O. Ojo, M. Danesi (Lagos, Nigeria)

    Objective: To determine the relationship between serum uric acid level and non-motor symptoms using the PD specific non-motor symptoms in Nigerian patients with Parkinson’s disease.…
  • 2018 International Congress

    Long-term efficacy and safety of incobotulinumtoxinA treatment for sialorrhea in Parkinson’s disease and other neurologic conditions

    F. Pagan, W. Jost, A. Friedman, O. Michel, C. Oehlwein, J. Slawek, A. Bogucki, S. Ochudlo, M. Banach, B. Flatau-Baqué, J. Csikós, A. Blitzer (Washington, DC, USA)

    Objective: SIAXI (NCT02091739), a pivotal double-blind, randomised, placebo-controlled study with a 48-week extension period (EP), assessed the efficacy and safety of incobotulinumtoxinA 75 U or…
  • « Previous Page
  • 1
  • …
  • 74
  • 75
  • 76
  • 77
  • 78
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley